Literature DB >> 11506560

Solution structures and reactivities of the mixed aggregates derived from n-butyllithium and vicinal amino alkoxides.

X Sun1, M D Winemiller, B Xiang, D B Collum.   

Abstract

Low-temperature (6)Li, (13)C, and (15)N NMR spectroscopies reveal that mixtures of n-BuLi and (1R,2S)-R'(2)NCH(R)CH(Ph)OLi (ROLi; R = Ph or Me; R'(2)N = pyrrolidino or Me(2)N) in THF/pentane afford a (n-BuLi)(3)(ROLi) (3:1) mixed tetramer and a C(2)-symmetric (n-BuLi)(2)(ROLi)(2) (2:2) mixed tetramer depending on the proportions of the reactants. The corresponding (n-BuLi)(ROLi)(3) (1:3) mixed tetramer is not observed. ROLi-mediated additions of n-BuLi to benzaldehyde proceed with up to 21:1 enantiomeric ratios that depend on the n-BuLi/ROLi stoichiometries. The enantioselectivities are considered in light of a previously posited mechanism involving reaction via the C(2)-symmetric 2:2 mixed tetramer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11506560     DOI: 10.1021/ja010136c

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  3 in total

1.  Enediolate-dilithium amide mixed aggregates in the enantioselective alkylation of arylacetic acids: structural studies and a stereochemical model.

Authors:  Yun Ma; Craig E Stivala; Ashley M Wright; Trevor Hayton; Jun Liang; Ivan Keresztes; Emil Lobkovsky; David B Collum; Armen Zakarian
Journal:  J Am Chem Soc       Date:  2013-05-31       Impact factor: 15.419

2.  The barrier to enantiomerization and dynamic resolution of N-Boc-2-lithiopiperidine and the effect of TMEDA.

Authors:  Iain Coldham; Daniele Leonori; Timothy K Beng; Robert E Gawley
Journal:  Chem Commun (Camb)       Date:  2009-08-06       Impact factor: 6.222

3.  Lithium Amino Alkoxide-Evans Enolate Mixed Aggregates: Aldol Addition with Matched and Mismatched Stereocontrol.

Authors:  Janis Jermaks; Evan H Tallmadge; Ivan Keresztes; David B Collum
Journal:  J Am Chem Soc       Date:  2018-02-19       Impact factor: 15.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.